This inventor holds 5 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1990-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Grasslfing, DE (1990 - 1995)
- Pentling, DE (2000 - 2003)
Company Filing History:
Years Active: 1990-2003
Title: **Erwin Von Angerer: A Pioneer in Antiestrogenic Pharmaceutical Agents**
Introduction
Erwin Von Angerer, based in Grasslfing, Germany, is an influential inventor recognized for his significant contributions to the pharmaceutical field. With a total of five patents to his name, he is particularly noted for his groundbreaking work on 2-phenylindoles, compounds that have promising applications as antiestrogenic agents.
Latest Patents
Among his latest innovations are the patents related to 2-phenylindoles as antiestrogenic pharmaceutical agents. These patents describe not only the compounds themselves but also a detailed process for their synthesis, pharmaceutical preparations that incorporate them, and methods for their use as effective pharmaceutical agents. This research has the potential to impact the treatment of various health conditions, highlighting Erwin's role in advancing medicinal science.
Career Highlights
Erwin Von Angerer is currently associated with Schering Aktiengesellschaft, a well-respected company in the pharmaceutical industry. His work at Schering has focused on developing innovative compounds that contribute to new therapeutic options for patients. His expertise and dedication to research have led to the creation of valuable intellectual property that extends the possibilities within pharmacology.
Collaborations
Throughout his career, Erwin has worked alongside notable colleagues such as Martin Schneider and Christian Biberger. Collaborating with skilled professionals in the field has enriched his research endeavors, fostering an environment of innovation and discovery that benefits the broader scientific community.
Conclusion
Erwin Von Angerer's contributions to the field of pharmaceuticals are commendable, particularly through his patented work on 2-phenylindoles. His affiliation with Schering Aktiengesellschaft and collaborations with industry experts reflect a commitment to advancing medical science. As he continues his work, the potential impact of his inventions may pave the way for new therapeutic developments in antiestrogenic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile